YaoGeJu

YaoGeJuCDE public lists · weekly counts

National Drug-Review Weekly

The available CDE acceptance records list 389 drug applications between 12 November 2026 and 18 November 2026 (data as of 23 November 2026). Of these, generic applications numbered 68, covering 47 drug names.

2026/11/12 – 2026/11/18

Period
2026/11/12 to 2026/11/18, 7 days inclusive
Data as of
2026/11/23
Loaded records
95,213 acceptance records, 11,351 under review now
Source
Public data from the CDE acceptance list and under-review list
New acceptances this week
389
Drugs with new generic filings (by drug name, de-duplicated)
47
Accepted this week, now under review
389

DefinitionAcceptance numbers accepted this week that are still on CDE's under-review list at the data cut-off; counted by acceptance date.

Names with a public page are linked.

New acceptances this week

By application type and drug type

389filings, 68 of them generic

By application type

Application typeFilings
Supplement203
New drug80
Generic68
Import27
Import re-registration6
Unspecified5

By drug type

Drug typeFilings
Chemical drug219
TCM96
Therapeutic biologic63
Biologic6
Prophylactic biologic5

DefinitionAcceptance numbers whose acceptance date falls in this week; application type and drug type are the CDE list's own text, with empty values shown as “Unspecified”.

Most new generic filings, by drug

47 drugs with new generic filings; top 10 listed

DefinitionThis week's acceptance numbers with application type “Generic”, grouped by identical drug name; filing companies are de-duplicated by first applicant; under review, all years = acceptance numbers for that name, from any year, still on the CDE under-review list. Top 10 by filings, then companies.

Most new acceptances, by company

244 companies with new acceptances; top 10 listed

#Company (first applicant)FilingsDrugsGeneric
1Henan Pu Rui Pharma Co., Ltd. romanized1480
2Eli Lilly and Company730
3CISEN PHARMACEUTICAL CO., LTD.633
4Novo Nordisk A/S610
5Shandong Bu Zhang Pharmaceutical Co., Ltd. romanized550
6Boehringer Ingelheim International GmbH520
7Beijing Tong Ren Tang Co., Ltd. Tong Ren Tang Pharmaceutical Factory romanized420
8Takeda Manufacturing Austria AG410
9Terumo Corporation Kofu Factory410
10Zhongshan Wanhan Pharmaceuticals Co., Ltd.410

DefinitionThis week's acceptance numbers grouped by first applicant; drugs are de-duplicated by drug name; “Generic” counts filings with application type “Generic”. Top 10 by filings.

Under-review list changes

Based on changes in CDE's under-review list

Entered review this week
419
Left the under-review list this week
729

Of these, NMPA published approval-document delivery for 366 (including 358 supplemental applications, not counted as new marketing approvals) and notification delivery for 22; the outcome of the other 341 is to be checked.

Most filings leaving review, by company

Most filings leaving review, by company
#Company (first applicant)FilingsDrugs
1Bai Ji Shen Zhou (Suzhou) Bio Technology Co., Ltd. romanized133
2Jiangsu Hengrui Pharmaceuticals Co.,Ltd.104
3Mu Dan Jiang Ling Tai Pharma Co., Ltd. romanized99
4AbbVie Inc.81
5Luo Yang Yi Long Pharma Co., Ltd. romanized77
6Shaanxi Dong Tai Pharmaceutical Co., Ltd. romanized77
7Shijiazhuang No.4 Pharmaceutical Co., Ltd.76
8Eli Lilly and Company72
9Novartis Pharma AG64
10Guangdong Tai En Kang Pharmaceutical Factory Co., Ltd. romanized62

Most filings entering review, by company

Most filings entering review, by company
#Company (first applicant)FilingsDrugs
1Henan Pu Rui Pharma Co., Ltd. romanized148
2Jiangsu Hengrui Pharmaceuticals Co.,Ltd.73
3Eli Lilly and Company63
4CISEN PHARMACEUTICAL CO., LTD.63
5Novo Nordisk A/S61
6Suzhou Ya Sheng Pharma Co., Ltd. romanized61
7Shandong Bu Zhang Pharmaceutical Co., Ltd. romanized55
8Anhui Sheng Jing Cheng Hui Yao Pharma Co., Ltd. romanized53
9Boehringer Ingelheim International GmbH52
10Beijing Tong Ren Tang Co., Ltd. Tong Ren Tang Pharmaceutical Factory romanized42

DefinitionEntered review = acceptance numbers first listed on CDE's under-review list this week, excluding numbers already listed on the record start date (2026/10/22). Left review = acceptance numbers last listed this week and no longer listed at the data cut-off; the outcome follows NMPA's approval-document delivery notices, and numbers without such a record are marked to be checked. Companies are counted by first applicant.

Class 3 and new-drug acceptances

119 this week

AcceptedDrugApplicants
2026/11/18Generic · Class 3 二硫化硒洗剂 · No verified English nameCYHS2602839 Anhui Tai Du Biopharmaceuticals Technology Co., Ltd. romanized; Yu Song Yuan Pharma Co., Ltd. romanized
2026/11/18Generic · Class 3 二硫化硒洗剂 · No verified English nameCYHS2602838 Anhui Tai Du Biopharmaceuticals Technology Co., Ltd. romanized; Yu Song Yuan Pharma Co., Ltd. romanized
2026/11/18New drug · Class 1.1 龙藤颗粒 · No verified English nameCXZL2600116 Heilongjiang Sheng Ji Ren Pharma Co., Ltd. romanized
2026/11/18New drug · Class 1 格斯泮妥塔单抗注射液 · No verified English nameCXSS2600190 Ming Ji Biopharmaceutical (Beijing) Co., Ltd. romanized
2026/11/18New drug · Class 1 LET003注射液 · No verified English nameCXSL2601284 He Bo Pharmaceuticals (Shanghai) Co., Ltd. romanized
2026/11/18New drug · Class 2.4 注射用重组A型肉毒毒素 · No verified English nameCXSL2601283 Jiangsu Yao Hai Nuo Xin Bio Technology Co., Ltd. romanized; Yao Hai Nuo Xin Bio Technology (Wuhan) Co., Ltd. romanized
2026/11/18New drug · Class 1 注射用GB268 · No verified English nameCXSL2601282 Yi Teng Pharmaceuticals (Zhuhai) Co., Ltd. romanized
2026/11/18New drug · Class 1 ALC01细胞注射液 · No verified English nameCXSL2601281 Ai Kai Li Yuan Bio Technology (Shanghai) Co., Ltd. romanized
2026/11/18New drug · Class 2.3 EP-0170T(Ⅰ) · No verified English nameCXHS2600154 Chengdu Shuo De Pharma Co., Ltd. romanized
2026/11/18New drug · Class 1 TER-2013片 · No verified English nameCXHL2601452 Bai Ji Shen Zhou (Shanghai) Bio Technology Co., Ltd. romanized
2026/11/18New drug · Class 1 TER-2013片 · No verified English nameCXHL2601451 Bai Ji Shen Zhou (Shanghai) Bio Technology Co., Ltd. romanized
2026/11/18New drug · Class 1 BG-75202片 · No verified English nameCXHL2601450 Bai Ji Shen Zhou (Suzhou) Bio Technology Co., Ltd. romanized
2026/11/18New drug · Class 1 BG-75202片 · No verified English nameCXHL2601449 Bai Ji Shen Zhou (Suzhou) Bio Technology Co., Ltd. romanized
2026/11/18New drug · Class 1 BG-75202片 · No verified English nameCXHL2601448 Bai Ji Shen Zhou (Suzhou) Bio Technology Co., Ltd. romanized
2026/11/18New drug · Class 1 MDN003注射液 · No verified English nameCXHL2601447 Mai De Nuo He Pharmaceuticals Technology (Sichuan) Co., Ltd. romanized
2026/11/17Import · Class 1 LUM-201胶囊 · No verified English nameJXHL2600517 Lumos Pharma LLC; ICON Clinical Research (Beijing No. 2) Co. Ltd.
2026/11/17Import · Class 1 LUM-201胶囊 · No verified English nameJXHL2600516 Lumos Pharma LLC; ICON Clinical Research (Beijing No. 2) Co. Ltd.
2026/11/17Import · Class 1 LUM-201胶囊 · No verified English nameJXHL2600515 Lumos Pharma LLC; ICON Clinical Research (Beijing No. 2) Co. Ltd.
2026/11/17Generic · Class 3 恩那度司他片 · No verified English nameCYHS2602837 Shandong Loncom Pharmaceutical Co., Ltd.
2026/11/17Generic · Class 3 恩那度司他片 · No verified English nameCYHS2602836 Shandong Loncom Pharmaceutical Co., Ltd.
2026/11/17Generic · Class 3 血管紧张素Ⅱ注射液 · No verified English nameCYHS2602828 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
2026/11/17New drug · Class 1 XKH001注射液 · No verified English nameCXSL2601280 Xin Kang He Biopharmaceuticals (Beijing) Co., Ltd. romanized; Beijing Xin Kang He Biopharmaceuticals Technology Co., Ltd. romanized
2026/11/17New drug · Class 1 DC01注射液 · No verified English nameCXSL2601279 Chengdu Bo An Zhi Yan Xi Bao Bio Technology Co., Ltd. romanized; Sichuan Zhong Ke Ding Yao Xi Bao Technology Co., Ltd. romanized
2026/11/17New drug · Class 1 PTT-936口服冻干粉 · No verified English nameCXHL2601446 Beijing Yan Ming Bio Technology Co., Ltd. romanized
2026/11/17New drug · Class 2.1; 2.2; 2.4 HW-N2001注射液 · No verified English nameCXHL2601445 HARWAY PHARMA CO.,LTD.
2026/11/17New drug · Class 1 ZL-69胶囊 · No verified English nameCXHL2601444 Chengdu Ze Ling Biopharmaceuticals Technology Co., Ltd. romanized
2026/11/17New drug · Class 1 ZL-69胶囊 · No verified English nameCXHL2601443 Chengdu Ze Ling Biopharmaceuticals Technology Co., Ltd. romanized
2026/11/17New drug · Class 1 ZL-69胶囊 · No verified English nameCXHL2601442 Chengdu Ze Ling Biopharmaceuticals Technology Co., Ltd. romanized
2026/11/16Import · Class 1 Zenagamtide片 · No verified English nameJXSL2600322 Novo Nordisk A/S; Novo Nordisk (China) Pharmaceuticals Co. Ltd
2026/11/16Import · Class 1 Zenagamtide片 · No verified English nameJXSL2600321 Novo Nordisk A/S; Novo Nordisk (China) Pharmaceuticals Co. Ltd

89 more not listed (at most 30 rows).

DefinitionThis week's acceptance numbers with application type “New drug”, or registration applications whose class starts with 1, 2 or 3 (supplements and re-registrations excluded); newest first, at most 30 rows.

Subscribe to the weekly

No account needed.

The email carries the same content as this page, in the language you subscribe in: section counts, top-10 lists and definitions, with a link to the full report. Your address is used only to send the report.

A text version of this report, weekly, in the language you subscribe in. You will receive one confirmation email first; sending starts only after you click its link. Every issue carries an unsubscribe link.